Welcome to Umecrine

Umecrine AB is active in research and development of pharmaceutical agents against negative mental and physical symptoms caused by natural CNS-active stress- and sex steroids (GABA-A receptor modulating steroids). There are several different indications on Umecrine's current work list, conditions related to e.g. anxiety and mood, memory, depression, overeating and regulation of satiety and appetite. Umecrine's portfolio includes a number of newly discovered lead compounds and several drug candidates that are under investigation.

The company was founded in 2000 by leading scientists at the University of Umeå, Sweden.



Torbjörn Bäckström

Chief Executive Officer

Phone +46 72 203 13 13



More contact details



Umeå Neurosteroid Research
Center (UNC)

Norrlands University Hospital

SE - 901 85 Umeå, Sweden


See on map



Umecrine AB

Registred office in Umeå

Reg no 556582-0684



© 2015 Umecrine